Medical Oncology Live Meeting Series

Gain expert insights from a medical oncologist on the optimal management of thyroid cancer with genomic aberrations in RET or NTRK.

Share

Program Content

Activities

  • Lung and Thyroid Cancer: Mol Alterations
    Genomic Alterations in Lung and Thyroid Cancer: Guidance on Molecular Testing for Precision Therapy
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 17, 2022

  • Lung and Thyroid Testing
    Genomic Alterations in Lung and Thyroid Cancer: Guidance on Molecular Testing for Precision Therapy
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 10, 2023

    Expires: April 09, 2024

Faculty

cover img faculity

Saad A. Khan, MD

Leader, Endocrine Cancer Research Group
Assistant Professor
Stanford University and Stanford Cancer Institute
Stanford, California

cover img faculity

Sandip P. Patel, MD

Professor, Medical Oncology, UC San Diego
Leader, Experimental Therapeutics
Deputy Director, Sanford Stem Cell Clinical Center
Co-Leader, Solid Tumor Therapeutics Program
Medical Director, Clinical Research Informatics
La Jolla, California

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Bayer Healthcare Pharmaceuticals Inc, Blueprint Medicines and Genentech, a member of the Roche Group, and Lilly.

Bayer HealthCare Pharmaceuticals Inc.

Blueprint Medicines and Genentech, a member of the Roche Group

Lilly

Partners

American Society for Clinical Pathology

ProCE Banner